journal article·2024-08-12

Engineering Thermo/pH-Responsive Lactoferrin Nanostructured Microbeads for Oral Targeting of Colorectal Cancer

Ahmed S. Abd Elhamid, Lamia Heikal, Doaa A. Ghareeb, Shaymaa A. Abdulmalek, Omar Mady, Mohamed Teleb, Sherine N. Khattab, Sanaa A. El-Gizawy

Publisher page

Abstract

AIM: Colorectal cancer is an extremely aggressive form of cancer that often leads to death. Lactoferrin shows potential for targeting and treating colorectal cancer; however, oral delivery faces hurdles hampering clinical applications. We engineered dual-responsive lactoferrin nanostructured microbeads to overcome delivery hurdles and enhance drug targeting. METHODS: The hydrophobic drug mesalazine (MSZ) was coupled to lactoferrin to form amphiphilic conjugate nanoparticles, dispersed in water. The lipid-soluble polyphenolic drug resveratrol (RSV) was then encapsulated into the hydrophobic core of LF-MSZ nanoparticles. To impart thermoresponsive properties, the dual-payload NPs were coupled with a PNIPAAm shell; finally, to further endow the nanoparticles with gastrointestinal resistance and pH responsiveness, the nanoparticles were microencapsulated into ionically cross-linked pectin-alginate beads. RESULTS: The nanoparticles showed enhanced internalization and cytotoxicity against HCT colon cancer cells via LF-receptor-mediated endocytosis. Thermal triggering and tuned release were conferred by the temperature-sensitive polymer. The coatings protected the drugs from degradation. Orally delivered microbeads significantly reduced tumor burden in a mouse colon cancer model, lowering carcinoembryonic antigen and elevating antioxidant enzymes. Apoptotic pathways were stimulated, indicated by heightened Bax/Bcl2 ratio and caspase-3/9 expression. CONCLUSION: Overall, we propose the innovative lactoferrin nanostructured microbeads as a paradigm shift in oral colorectal cancer therapeutics.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Infant Nutrition and Health · Graphene and Nanomaterials Applications · Supramolecular Self-Assembly in Materials

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmaceutical Technology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt

Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt

Bio-screening and Preclinical Trial Lab, Biochemistry Department, Faculty of Science, Alexandria University, Alexandria 21511, Egypt

Center of Excellence for Drug Preclinical Studies (CE-DPS), Pharmaceutical and Fermentation Industry Development Center, City of Scientific Research & Technological Applications, New Borg El Arab, Alexandria 21934, Egypt

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt

Chemistry Department, Faculty of Science, Alexandria University, Alexandria 21321, Egypt

Funding

Science and Technology Development Fund

References (73)

Show source-provided references
1. 10.3322/caac.2149210.3322/caac.21492 ↗
2. 10.1136/gutjnl-2015-31091210.1136/gutjnl-2015-310912 ↗
3. 10.1111/j.0022-202X.2005.23724.x10.1111/j.0022-202X.2005.23724.x ↗
4. 10.1016/j.freeradbiomed.2010.09.00610.1016/j.freeradbiomed.2010.09.006 ↗
5. 10.3892/ol.2016.433110.3892/ol.2016.4331 ↗
6. 10.1053/j.gastro.2010.01.05810.1053/j.gastro.2010.01.058 ↗
7. 10.1158/1940-6207.CAPR-08-016010.1158/1940-6207.CAPR-08-0160 ↗
8. 10.1126/science.275.5297.21810.1126/science.275.5297.218 ↗
9. 10.3390/nu910107310.3390/nu9101073 ↗
10. 10.1139/o01-21410.1139/o01-214 ↗
11. 10.1038/nrc195810.1038/nrc1958 ↗
12. 10.1016/j.addr.2009.10.00410.1016/j.addr.2009.10.004 ↗
13. 10.1038/s41598-020-61605-y10.1038/s41598-020-61605-y ↗
14. 10.1080/08927014.2013.77331710.1080/08927014.2013.773317 ↗
15. 10.1097/MCO.0b013e328328d13e10.1097/MCO.0b013e328328d13e ↗
16. 10.1038/nmat377610.1038/nmat3776 ↗
17. 10.1016/j.jcis.2021.12.12610.1016/j.jcis.2021.12.126 ↗
18. 10.1080/10717544.2022.205864610.1080/10717544.2022.2058646 ↗
19. 10.1016/j.ijbiomac.2020.02.13210.1016/j.ijbiomac.2020.02.132 ↗
20. 10.1021/acs.bioconjchem.8b0042810.1021/acs.bioconjchem.8b00428 ↗
21. 10.2217/nnm-2018-000610.2217/nnm-2018-0006 ↗
22. 10.1248/cpb.58.50110.1248/cpb.58.501 ↗
23. 10.1246/bcsj.2010007510.1246/bcsj.20100075 ↗
24. 10.2217/nnm-2018-019610.2217/nnm-2018-0196 ↗
25. 10.1016/j.jconrel.2017.01.03510.1016/j.jconrel.2017.01.035 ↗
26. 10.1016/j.colsurfb.2021.11169410.1016/j.colsurfb.2021.111694 ↗
27. 10.3109/10717544.2013.87710010.3109/10717544.2013.877100 ↗
28. 10.1039/C8NR03828G10.1039/C8NR03828G ↗
29. 10.1007/s10904-021-02133-810.1007/s10904-021-02133-8 ↗
30. 10.2147/ijn.s12557310.2147/ijn.s125573 ↗
31. 10.2147/ijn.s4661310.2147/ijn.s46613 ↗
32. 10.1016/S2222-1808(12)60151-010.1016/S2222-1808(12)60151-0 ↗
33. 10.4103/0975-7406.9482510.4103/0975-7406.94825 ↗
34. 10.1016/j.mrgentox.2004.06.00510.1016/j.mrgentox.2004.06.005 ↗
35. 10.1111/j.1432-1033.1974.tb03714.x10.1111/j.1432-1033.1974.tb03714.x ↗
36. Montgomery H. · Analyst · 1971 · 1 · 123
37. 10.1016/S0021-9258(18)38465-510.1016/S0021-9258(18)38465-5 ↗
38. 10.1373/clinchem.2010.14976510.1373/clinchem.2010.149765 ↗
39. Bancroft J. D. · 2008
40. 10.3390/molecules2006970310.3390/molecules20069703 ↗
41. 10.1093/ecco-jcc/jjx05610.1093/ecco-jcc/jjx056 ↗
42. 10.1007/s10534-016-9973-x10.1007/s10534-016-9973-x ↗
43. 10.1007/s00396-009-2028-x10.1007/s00396-009-2028-x ↗
44. 10.3390/ph1602021410.3390/ph16020214 ↗
45. 10.1016/j.progpolymsci.2004.08.00310.1016/j.progpolymsci.2004.08.003 ↗
46. 10.1016/j.ejpb.2008.11.01010.1016/j.ejpb.2008.11.010 ↗
47. 10.1016/j.addr.2006.09.02010.1016/j.addr.2006.09.020 ↗
48. 10.1021/acs.biomac.3c0003710.1021/acs.biomac.3c00037 ↗
49. 10.1186/2008-2231-21-5810.1186/2008-2231-21-58 ↗
50. 10.1021/acsami.5b0282110.1021/acsami.5b02821 ↗
51. 10.1088/0957-4484/22/26/26560810.1088/0957-4484/22/26/265608 ↗
52. 10.1002/aoc.669110.1002/aoc.6691 ↗
53. 10.1016/j.msec.2019.11041810.1016/j.msec.2019.110418 ↗
54. 10.1016/0065-2571(84)90007-410.1016/0065-2571(84)90007-4 ↗
55. 10.1139/o06-05810.1139/o06-058 ↗
56. 10.2174/13816120978845320210.2174/138161209788453202 ↗
57. 10.1016/j.bbagen.2011.06.01810.1016/j.bbagen.2011.06.018 ↗
58. 10.1139/o11-05610.1139/o11-056 ↗
59. 10.1039/c2tb00223j10.1039/c2tb00223j ↗
60. Mobaraki V. · 2014
61. Sriamornsak P. · Silpakorn Univ. Int. J. · 2003 · 3 · 206
62. 10.1016/j.ijpharm.2008.07.01810.1016/j.ijpharm.2008.07.018 ↗
63. 10.1080/00222348.2015.111055110.1080/00222348.2015.1110551 ↗
64. 10.1016/S0168-3659(99)00181-910.1016/S0168-3659(99)00181-9 ↗
65. 10.5455/medarh.2013.67.397-40110.5455/medarh.2013.67.397-401 ↗
66. 10.4103/jcrt.JCRT_862_1610.4103/jcrt.JCRT_862_16 ↗
67. 10.1016/j.biocel.2006.07.00110.1016/j.biocel.2006.07.001 ↗
68. 10.1038/nature0720510.1038/nature07205 ↗
69. 10.1016/j.cell.2010.01.02510.1016/j.cell.2010.01.025 ↗
70. 10.1038/sj.onc.121022010.1038/sj.onc.1210220 ↗
71. 10.1016/j.cell.2011.02.01310.1016/j.cell.2011.02.013 ↗
72. 10.1016/j.humimm.2004.01.00410.1016/j.humimm.2004.01.004 ↗
73. 10.1126/science.119868710.1126/science.1198687 ↗